The 2024 Annual Report highlights a year of strategic growth, expanded research, and a strengthened focus on patient-centered and equity-driven value research following the organization’s rebrand as the Center for Innovation & Value Research. The Center directed 70% of total revenue to research ($1.1M), welcomed 10 new members, and engaged more than 260 stakeholders at its Methods Summit. Major accomplishments include the launch of the Blueprint for Patent-Centered Value Research, expansion of the Patient-Centered Economic Impacts workshop series, advancement of rare-disease patient-engagement tools, and continued leadership through the Health Equity Program and its multi-report equity framework. The report also documents a strong national presence through conferences and publications, enhanced communications and outreach, and a diversified membership base, reinforcing the Center’s role as a leader in advancing transparent, inclusive, and actionable health technology assessment that reflects what matters most to patients and caregivers.
